Morgan Stanley’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
|
|||||
|
2025
Q1 | $4.34M | Buy |
|
|||||
|
2024
Q4 | $2.67M | Sell |
|
|||||
|
2024
Q3 | $9.45M | Buy |
|
|||||
|
2024
Q2 | $9.31M | Sell |
|
|||||
|
2024
Q1 | $16.6M | Sell |
|
|||||
|
2023
Q4 | $20.7M | Buy |
|
|||||
|
2023
Q3 | $8.31M | Buy |
|
|||||
|
2023
Q2 | $7.91M | Sell |
|
|||||
|
2023
Q1 | $8.7M | Buy |
|
|||||
|
2022
Q4 | $3.48M | Sell |
|
|||||
|
2022
Q3 | $5.72M | Sell |
|
|||||
|
2022
Q2 | $30.4M | Sell |
|
|||||
|
2022
Q1 | $44M | Buy |
|
|||||
|
2021
Q4 | $27.2M | Buy |
|
|||||
|
2021
Q3 | $623K | Sell |
|
|||||
|
2021
Q2 | $979K | Buy |
|
|||||
|
2021
Q1 | $89K | Buy |
|
|||||
|
2020
Q4 | $38K | Hold |
|
|||||
|
2020
Q3 | $27K | Sell |
|
|||||
|
2020
Q2 | $31K | Sell |
|
|||||
|
2020
Q1 | $62K | Buy |
|
|||||
|
2019
Q4 | $53K | Sell |
|
|||||
|
2019
Q3 | $70K | Buy |
|
|||||
|
2019
Q2 | $61K | Buy |
|
|||||
|
2019
Q1 | $49K | Sell |
|
|||||
|
2018
Q4 | $219K | Buy |
|
|||||
|
2018
Q3 | $115K | Buy |
|
|||||
|
2018
Q2 | $29K | Buy |
|
|||||
|
2018
Q1 | $8K | Sell |
|
|||||
|
2017
Q4 | $30K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $259K | Buy |
|
|||||
|
2017
Q1 | $4K | Sell |
|
|||||
|
2016
Q4 | $9K | Sell |
|
|||||
|
2016
Q3 | $23K | Buy |
|
|||||
|
2016
Q2 | $5K | Hold |
|
|||||
|
2016
Q1 | $6K | Hold |
|
|||||
|
2015
Q4 | $7K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $33K | Buy |
|
|||||
|
2015
Q1 | $5K | Buy |
|
|||||
|
2014
Q4 | $0 | Buy |
|